Loading…

Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.391-393
Main Authors: Bahlis, Nizar Jacques, Tomasson, Michael H., Mohty, Mohamad, Niesvizky, Ruben, Nooka, Ajay K., Manier, Salomon, Maisel, Christopher, Jethava, Yogesh, Martinez-Lopez, Joaquin, Prince, H Miles, Arnulf, Bertrand, Rodriguez Otero, Paula, Koehne, Guenther, Touzeau, Cyrille, Raje, Noopur, Iida, Shinsuke, Raab, Marc-Steffen, Leip, Eric, Sullivan, Sharon, Conte, Umberto, Viqueira, Andrea, Lesokhin, Alexander M
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-162440